When a baby is born, their bodies are overwhelmed in many ways. But in one particular way, a surge of microbes go into their gut, which come from the mother’s birth canal, gut and skin. That kind of sounds bad, but there is an upside, and it appears to depend partially on the mother’s DNA. […]
Diabetes drug metformin may be as effective as it’s ubiquitous, but it’s known to throws the stomach’s balance out of whack. Half the patients experience diarrhea and a quarter vomiting, so patients often scale back on metformin – or stop using it entirely. Also, microbiome imbalances are consistently being linked now to obesity. Colorado startup MicroBiome Therapeutics is […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Cambridge-based Seres Health, a contender in the haute field of microbiome therapeutics, just hauled in a $48 million Series C round. The startup’s developing biologics that target recurrent C. difficile infections – a real nuisance in the realm of hospital-acquired infections. The company plans to use the funding to advance its lead candidate, SER-109, into Phase 3 clinical trials. If approved, Seres’ […]
Seres Health has raised $10 million to advance its C.difficile therapeutic to treat strains resistant to the antibiotic vancomycin, according to a company statement. It wants to combat the increasing threat hospital acquired infections pose to patients. But this innovative approach to medicine also faces some regulatory challenges. The Mayo Clinic was among the new […]